Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Julphar
Fuji
Boehringer Ingelheim
Healthtrust
US Army
Federal Trade Commission
Johnson and Johnson

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Ibuprofen; Pseudoephedrine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00240812 A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting Completed Johnson & Johnson Consumer and Personal Products Worldwide Phase 2 The purpose of the study is to determine if ibuprofen in combination with pseudoephedrine HCl in the treatment of nightime bedwetting in children is more effective than each drug alone and if the individual drugs are more effective than placebo.
NCT01131780 Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions Completed Dr. Reddy's Laboratories Limited Phase 1 The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fasting conditions.
NCT01132222 Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions Completed Dr. Reddy's Laboratories Limited Phase 1 The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fed conditions.
NCT01170637 Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers Completed Boehringer Ingelheim Phase 1 The objective of the current study is to demonstrate bioequivalence of a fixed dose combination tablet containing ibuprofen 200 mg and pseudoephedrine-HCl 30 mg (Test) and RhinAdvil® (Reference) a fixed dose combination tablet containing ibuprofen 200 mg and pseudoephedrine-HCl 30 mg following orally administration.
NCT02963701 Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Health Not yet recruiting Boehringer Ingelheim Phase 1 The objective of the current study is to demonstrate bioequivalence of a fixed dose combination tablet containing ibuprofen 400 mg and pseudoephedrine-HCl 60 mg (Test) and two tablets RhinAdvil® (Reference) a fixed dose combination tablet containing ibuprofen 200 mg and pseudoephedrine-HCl 30 mg following orally administration with respect to both analytes, ibuprofen and pseudoephedrine-HCl.
NCT03429738 Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets Completed Pharma Medica Research, Inc. Phase 1 Evaluation of the comparative bioavailability between two oral formulations containing ibuprofen 200 mg and pseudoephedrine 30 mg after a single dose in healthy subjects under fasting conditions.
NCT03429738 Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets Completed Institut für Pharmakologie und Präventive Medizin Phase 1 Evaluation of the comparative bioavailability between two oral formulations containing ibuprofen 200 mg and pseudoephedrine 30 mg after a single dose in healthy subjects under fasting conditions.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ibuprofen; Pseudoephedrine Hydrochloride

Condition Name

Condition Name for Ibuprofen; Pseudoephedrine Hydrochloride
Intervention Trials
Healthy 3
Healthy Volunteers 1
Fever 1
Enuresis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ibuprofen; Pseudoephedrine Hydrochloride
Intervention Trials
Nocturnal Enuresis 1
Enuresis 1
Headache 1
Back Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ibuprofen; Pseudoephedrine Hydrochloride

Trials by Country

Trials by Country for Ibuprofen; Pseudoephedrine Hydrochloride
Location Trials
India 2
Canada 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ibuprofen; Pseudoephedrine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ibuprofen; Pseudoephedrine Hydrochloride
Clinical Trial Phase Trials
Phase 2 1
Phase 1 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ibuprofen; Pseudoephedrine Hydrochloride
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ibuprofen; Pseudoephedrine Hydrochloride

Sponsor Name

Sponsor Name for Ibuprofen; Pseudoephedrine Hydrochloride
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
Boehringer Ingelheim 2
Johnson & Johnson Consumer and Personal Products Worldwide 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ibuprofen; Pseudoephedrine Hydrochloride
Sponsor Trials
Industry 6
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Queensland Health
Medtronic
US Department of Justice
UBS
Julphar
Chubb
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.